Results 71 to 80 of about 3,211 (100)

Exploring the Landscape of Immune Checkpoint Inhibitor-Induced Adverse Events Through Big Data Mining of Pan-Cancer Clinical Trials. [PDF]

Oncologist
Fadlullah MZH, Lin CN, Coleman S, Young A, Naqash AR, Hu-Lieskovan S, Tan AC.   +6 more
europepmc   +1 more source

No longer uncertain: the validation of tenebrionid insects as hosts of <i>Blattambidensovirus incertum1</i> isolates by phylogeny and infection studies. [PDF]

J Gen Virol
Lim FS, González-Cabrera J, Jehle JA, Lefebvre T, Wennmann JT.   +4 more
europepmc   +1 more source

Detrimental effect of an early exposure to antibiotics on the outcomes of immunotherapy in a multi-tumor cohort of patients. [PDF]

Oncologist
Guerrero P, Albarrán V, González-Merino C, García de Quevedo C, Sotoca P, Chamorro J, Rosero DI, Barrill A, Alía V, Calvo JC, Moreno J, Pérez de Aguado P, Álvarez-Ballesteros P, San Román M, Serrano JJ, Soria A, Olmedo ME, Saavedra C, Cortés A, Gómez A, Lage Y, Ruiz Á, Ferreiro MR, Longo F, Guerra E, Martínez-Delfrade Í, Garrido P, Gajate P.   +27 more
europepmc   +1 more source

Association of immune checkpoint inhibitors with muscle mass and density in patients with melanoma. [PDF]

Oncologist
Ziolkowski S, Matheson BE, Boyd SK, Walle M, Gill J, Walker J, Salopek T, Baker JF, Fettahoglu A, Ye C.   +9 more
europepmc   +1 more source

Evaluating Food and Drug Administration approved gastrointestinal cancer drugs: clinical benefit and trial endpoints over the past two decades. [PDF]

Oncologist
Jamal F, Sahvan O, Junior PLSU, Jones JC, Ou FS, Bekaii-Saab T, Sonbol MB.   +6 more
europepmc   +1 more source

First-line PD-1 +/- CTLA-4 blockade in patients with deficient mismatch repair and/or microsatellite instability-high metastatic colorectal cancer. [PDF]

Oncologist
Nasca V, Tinè G, Taieb J, Lonardi S, Boursi B, Margalit O, Salvatore L, Cohen R, Ros J, Ambrosini M, Zwart K, Roodhart J, Jayachandran P, Overman MJ, Elez ME, Cremolini C, Tougeron D, Koopman M, André T, Miceli R, Pietrantonio F.   +20 more
europepmc   +1 more source

Vorwort

Zeitschrift für Rezensionen zur Germanistischen Sprachwissenschaft, 2015
doaj   +1 more source

PARP inhibitor therapy in patients with IDH1 mutated cholangiocarcinoma. [PDF]

Oncologist
Mohan A, Quingalahua E, Gunchick V, Paul S, Kumar-Sinha C, Crysler O, Zalupski MM, Sahai V.   +7 more
europepmc   +1 more source